Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FDL88
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,114
Award facts
- Contract value 100% obligated
- $43,113.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $43,113.50 by the Defense Logistics Agency on September 16, 2025, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, which is expected to be completed by September 17, 2025, was issued without a set-aside designation, allowing the vendor to compete directly in the open federal procurement market. The place of performance is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its operations.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This comprehensive IDC enables the agency to procure an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables, to support the medical supply needs of Department of Defense healthcare facilities worldwide. Xtandi, an oncology medication, is consistent with the vendor's established track record of supplying specialized pharmaceutical products to military and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FDL88?
SPE2DB25FDL88 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FDL88 worth?
The government has obligated $43,114 on SPE2DB25FDL88.
Is contract SPE2DB25FDL88 an order under another contract?
Yes. SPE2DB25FDL88 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL88 competed?
The extent of competition for SPE2DB25FDL88 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award